Glossary
Ingredient Label
Updated February 28, 2026
Your ingredient label is your contract with the product; it should tell you what active compounds you are dosing and how consistent the product is across batches.
Why it matters
If the label is unclear, your dose logs and recommendation output become noisy and harder to verify for safety or effectiveness.
Label mini-framework
Use six fields as a fast read:
- Active ingredient name and exact quantity
- Chemical form (citrate, bisglycinate, capsule, powder)
- Excipient list and non-active fillers
- Serving size and servings per container
- Batch or lot code
- Third-party testing statement
Certification symbols and what they actually mean
- USP, NSF, or Informed-Choice can indicate testing practices, but symbols rarely guarantee clinical efficacy.
- Good symbols reduce contamination risk; they do not prove perfect absorption or guarantee interaction safety.
- Missing symbols are not automatically dangerous, but they should prompt closer scrutiny and smaller initial doses.
Common traps
- Proprietary blends that hide gram-by-gram ingredient amounts
- Allergen disclosures that are incomplete or vague
- Ingredients listed as "and extract complex" without marker content
- Dose per serving that changes across formats (softgel vs caplet)
- Claims written as outcomes without required ingredient context
Practical action step
Before logging a new supplement, verify total active mg per recommended serving and save a screenshot of the full label page for your own comparison history.
Uncertainty and limits
- Evidence is limited on label accuracy consistency for products sold under private labels and cross-border sourcing.
- Evidence is limited on how often quality statements are independently audited versus self-reported.
Cross-site references
How this appears in Unfair
Unfair uses consistent label parsing to fill ingredient metadata, compare duplicates, and apply dosing ceilings that depend on form and disclosed purity.
Clinical safety note
If a label changes unexpectedly without a lot number explanation, pause that product, retest with a newer lot, and escalate for clinician review if symptoms have changed.